ArticleFrontiers in oncology2026

Targeting MEST using cobicistat as a therapeutic strategy for gastric cancer through suppressing NF-κB signaling.

Hongtai Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.